Indoco Remedies moves up on getting EU GMP certification for Goa manufacturing site
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Indoco Remedies is currently trading at Rs. 324.35, up by 1.60 points or 0.50% from its previous closing of Rs. 322.75 on the BSE.
The scrip opened at Rs. 323.80 and has touched a high and low of Rs. 327.00 and Rs. 323.15 respectively. So far 3621 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 423.10 on 02-Jan-2023 and a 52 week low of Rs. 307.00 on 26-Apr-2023.
Last one week high and low of the scrip stood at Rs. 331.50 and Rs. 317.95 respectively. The current market cap of the company is Rs. 2997.65 crore.
The promoters holding in the company stood at 58.69%, while Institutions and Non-Institutions held 19.60% and 21.70% respectively.
Indoco Remedies has received EU GMP certification from the Competent Health Authority of Germany for its manufacturing site situated at L-32/33/34 Verna Industrial Estate, Goa. The European Agency conducted an inspection at Indoco’s manufacturing facility for solid oral dosage form in Goa (Plant -III) from April 20-25, 2023.
The EU GMP certification issued by the German Health Authority (LAGeSo) confirms that the site complies with the Good Manufacturing Practice requirements as referred to in the EC Directive. The EU certification will support supplies of drug products registered in Europe and other regions from this manufacturing site.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
